No Data
Shijiazhuang Yiling Pharmaceutical's (SZSE:002603) Problems Go Beyond Weak Profit
Eling Pharmaceutical: Report for the third quarter of 2024
Shijiazhuang Yiling Pharmaceutical (002603.SZ): net income of 0.555 billion yuan in the first three quarters, a year-on-year decrease of 68.46%.
GeLongHui, October 28th - Shijiazhuang Yiling Pharmaceutical (002603.SZ) announced its third quarter report for 2024, achieving revenue of 6.365 billion yuan in the first three quarters, a decrease of 25.76% year-on-year; net income attributable to shareholders of the listed company was 0.555 billion yuan, a decrease of 68.46% year-on-year; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 0.507 billion yuan, a decrease of 69.07% year-on-year; basic earnings per share were 0.3321 yuan.
shijiazhuang yiling pharmaceutical (002603.SZ) released its performance for the first three quarters, with a net income of 0.555 billion yuan, a 68.46% year-on-year decrease.
Shijiazhuang Yiling Pharmaceutical (002603.SZ) released the third quarter report of 2024. In the first three quarters, the company achieved revenue...
Express News | Yiling Pharma Q3 Net Profit Down 84.1% Y/Y
Insiders Were the Key Beneficiaries as Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s (SZSE:002603) Market Cap Rises to CN¥29b
Benign Growth For Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SZSE:002603) Underpins Its Share PriceNo Data
No Data
